The Pharmacy Times® Coronavirus resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with temperate climates, but only when herd immunity is attained through natural infection or vaccinations.
The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Top news of the week from Pharmacy Times®.
Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.
Experts: Working from Home is Largest Challenge for Specialty Pharmacy During COVID-19, But Has Unexpected Benefits
Although working from home created challenges for contacting stakeholders, some companies saw higher accuracy and fewer sick days among employees.
PTCE Announces David DeRemer as Keynote Speaker for Virtual Directions in Oncology Pharmacy® 2020 Fall Conference Series
The keynote presentation will be broadcast virtually on 4 dates this fall and highlight cancer-specific guidance for pharmacists during the COVID-19 pandemic.
A study of Chinese women found COVID-19 heightened stress, fear, and depression during pregnancy.
Following the global impact of COVID-19 on the health care system in 2020, there have been some clear changes in HIV care in the United States.
The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.
Students at the University of Illinois at Chicago College of Pharmacy answered the question “How has the pandemic impacted your summer internship/residency (or other pharmacy work)?”
In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.
Although the presence of rhinovirus limited the ability of influenza to infect cells, researchers do not know whether the same effect will be seen with COVID-19.